Page last updated: 2024-08-24

fluorodeoxyglucose f18 and diatrizoate meglumine

fluorodeoxyglucose f18 has been researched along with diatrizoate meglumine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dizendorf, EV; Hany, TF; Treyer, V; Von Schulthess, GK	1
Cohade, C; Fishman, EK; Links, JM; Marshall, LT; Nakamoto, Y; Osman, M; Wahl, RL	1
Bomanji, JB; Croasdale, I; Dickson, JC; Ell, PJ; Groves, AM; Hain, SF; Kayani, I; Nagabushan, N; Syed, R; Townsend, C	1
Coya, J; Del Campo-Del Val, L; Gómez-León, N; Hernandez-Maraver, D; Jover-Díaz, R; Pinilla, I; Rodríguez-Vigil, B	1
Haerle, SK; Hany, TF; Huber, G; Schaefer, NG; Schmid, D; Seifert, B; Soyka, JD; Strobel, K; Studer, G; Veit-Haibach, P	1
Guo, Q; Liu, C; Ma, Q; Xin, J; Xu, W; Yu, S; Zhai, W; Zhao, Z	1
Fox, JJ; Goldman, DA; Gonen, M; Hricak, H; Kuk, D; Larson, SM; Morris, MJ; Scher, HI; Vargas, HA; Wassberg, C; Wibmer, A	1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and diatrizoate meglumine

Article	Year
Oral contrast medium in PET/CT: should you or shouldn't you? European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10 Topics: Abdominal Neoplasms; Administration, Oral; Artifacts; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed	2005

Article

Year

Oral contrast medium in PET/CT: should you or shouldn't you?

European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:10

Topics: Abdominal Neoplasms; Administration, Oral; Artifacts; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed

2005

Other Studies

6 other study(ies) available for fluorodeoxyglucose f18 and diatrizoate meglumine

Article	Year
Application of oral contrast media in coregistered positron emission tomography-CT. AJR. American journal of roentgenology, 2002, Volume: 179, Issue:2 Topics: Administration, Oral; Adult; Aged; Contrast Media; Diatrizoate Meglumine; Digestive System; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2002
Initial experience with oral contrast in PET/CT: phantom and clinical studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:3 Topics: Administration, Oral; Artifacts; Barium Sulfate; Contrast Media; Diatrizoate Meglumine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Intestines; Male; Middle Aged; Neck Muscles; Phantoms, Imaging; Radiopharmaceuticals; Stomach; Tomography, Emission-Computed; Tomography, X-Ray Computed	2003
Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiation Dosage; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2011
Combined PET/CT-perfusion in patients with head and neck cancers. European radiology, 2013, Volume: 23, Issue:1 Topics: Adult; Aged; Biopsy; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Iohexol; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Statistics, Nonparametric; Tomography, X-Ray Computed	2013
Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension. European journal of radiology, 2013, Volume: 82, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed	2013
Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival. Radiology, 2014, Volume: 271, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Cross-Sectional Studies; Diatrizoate; Diatrizoate Meglumine; Dihydrotestosterone; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Androgen; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed	2014